David Levy, MD

216.444.5600

David Levy, MD

Appointed: 2008

David Levy, MD
Department: Urology
Location: Beachwood Family Health Center
26900 Cedar Road
Beachwood, OH 44122
WorkAppointment:216.444.5600
WorkFax:216.692.8999
David Levy, MD
Department: Urology
Location: Euclid Medical Office
99 Northline Circle
Euclid, OH 44119
WorkAppointment:216.444.5600
WorkFax:216.692.8999
Surgeon:
Yes
Treats:
Adults Only

Biographical Sketch

Dr. David Levy graduated with a degree in Anthropology from Washington University in St. Louis. He earned his medical degree from The Chicago Medical School and did his residency in Urology at University Hospitals Case Medical Center. Following his residency he earned a fellowship in Urologic Oncology at The University of Texas M D Anderson Cancer Center in Houston Texas.

Dr. Levy has authored 23 scientific manuscripts and 19 book chapters. He is also the founding editor of a Urology board review book now in it's third edition. Additionally, he has been an invited speaker at numerous national meetings and is a recognized expert in prostate cryosurgery. His main focus in clinical practice is minimally invasive kidney and prostate cancer therapy.

Education & Fellowships

Fellowship - University of Texas M.D. Anderson Cancer Center
Urologic Oncology
Houston, TX USA
1997
Residency - University Hospitals of Cleveland
Urology
Cleveland, OH USA
1995
Internship - University Hospitals of Cleveland
General Surgery
Cleveland, OH USA
1991
Medical School - University of Health Sciences, The Chicago Medical School
North Chicago, IL USA
1989
Undergraduate - Washington University
St. Louis, MO USA
1985

Certifications

  • Urology

Specialty Interests

oncology, prostate cancer, kidney cancer and bladder cancer

Awards & Honors

  • "Methods in Clinical Cancer Research"American Association for Cancer Research/American Society of Clinical Oncology. Invited sponsored seminar participant, Park City, Utah August 1996
  • Research funds competition for Clinical Trainees 1996-1997$0The University of Texas M.D. Anderson Cancer Center “Site Specific Intraprostatic Carmustine Injection: A Feasibility Study in the Canine Model”
  • Best Poster - Clinical Renal Neoplasms: Abstract # 276 “Feasibility of Cytoreductive Surgery Prior to Systemic Biologic Therapy in Carefully Selected Metastatic RCC.”: American Urological Association, Annual Meeting, New Orleans, LA: April 1997.
  • Reviewer, Doody Enterprises, Inc. 500 N. Michigan Ave., Suite 1410 Chicago, IL 60611 February 2007 – present.
  • Nationally Recognized expert in Prostate Cryosurgery: ProstateCancer.com Cryocare, 2005.
  • Reviewer, The Journal of Urology: Renal cell carcinoma and Prostate cancer. April 2007- present.
  • Surgical Proctor Renal / Prostate Cryosurgical Techniques. Endocare Inc. Proctor, June 2007 – present.
  • Fox News 8, Your Health Featured in Prostate Cryosurgery segment.
  • Cleveland Channel 3 Golden Opportunities featured segment Cryosurgery. December 28, 2008.

Memberships

  • American Urological Association
  • North Central Section, American Urologic Association
  • Society of Urologic Oncology
  • American Society for Clinical Urologists
  • American Cancer Society

Treatment & Services

  • Benign Prostate Surgery
  • Brachytherapy
  • Circumcision
  • Cryotherapy
  • Cystectomy
  • Ileal Conduit
  • Laparoscopic and Robotic-Assisted Laparoscopy
  • Laparoscopic Nephrectomy
  • Laparoscopic Renal Cryoablation
  • Partial Nephrectomy
  • Post Vasectomy Screen
  • Prostate Biopsy
  • Prostate Brachytherapy
  • Radical Cystectomy
  • Radical Nephrectomy: Laparoscopic Or Open
  • Retroperitoneal Lymph Node Dissection
  • Stents
  • TURP (Transurethral Resection of The Prostate)
  • Urinary Diversion
  • Urology
  • Vasectomy

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 11/15/2013, Dr. Levy has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
Cleveland Clinic Mobile Site